187 related articles for article (PubMed ID: 19782245)
1. Toxicants and neurodegenerative diseases special issue.
Gupta RC; Milatovic D
Toxicol Appl Pharmacol; 2009 Oct; 240(2):123. PubMed ID: 19782245
[No Abstract] [Full Text] [Related]
2. Solvent neurotoxicity.
Dick FD
Occup Environ Med; 2006 Mar; 63(3):221-6, 179. PubMed ID: 16497867
[No Abstract] [Full Text] [Related]
3. [Neurobehavioral tests in occupational medicine: diagnosis and prevention].
Albini E; Benedetti L
G Ital Med Lav Ergon; 2004; 26(3):251-4. PubMed ID: 15551956
[TBL] [Abstract][Full Text] [Related]
4. Special issue: Environmental chemicals and neurotoxicity.
Gupta RC; Milatovic D
Toxicol Appl Pharmacol; 2011 Nov; 256(3):217-8. PubMed ID: 21856325
[No Abstract] [Full Text] [Related]
5. Role of Environmental Chemical Insult in Neuronal Cell Death and Cytoskeleton Damage.
Aung KH; Tsukahara S; Maekawa F; Nohara K; Nakamura K; Tanoue A
Biol Pharm Bull; 2015; 38(8):1109-12. PubMed ID: 26235574
[TBL] [Abstract][Full Text] [Related]
6. Pseudoneurotoxic disease.
Schaumburg HH; Albers JW
Neurology; 2005 Jul; 65(1):22-6. PubMed ID: 16009881
[No Abstract] [Full Text] [Related]
7. Stormy weather.
Weiss B
Neurotoxicology; 2016 Sep; 56():233. PubMed ID: 27692541
[No Abstract] [Full Text] [Related]
8. Symposium overview: Do environmental agents enter the brain via the olfactory mucosa to induce neurodegenerative diseases?
Doty RL
Ann N Y Acad Sci; 2009 Jul; 1170():610-4. PubMed ID: 19686201
[No Abstract] [Full Text] [Related]
9. Severe neurotoxicity following oral meperidine (pethidine) overdose.
Karunatilake H; Buckley NA
Clin Toxicol (Phila); 2007; 45(2):200-1. PubMed ID: 17364646
[No Abstract] [Full Text] [Related]
10. Introduction to the special issue on environmental risk assessment of pharmaceuticals.
Knacker T; Metcalfe C
Integr Environ Assess Manag; 2010 Jul; 6 Suppl():511-3. PubMed ID: 20821716
[No Abstract] [Full Text] [Related]
11. Neurological risks associated with manganese exposure from welding operations--a literature review.
Flynn MR; Susi P
Int J Hyg Environ Health; 2009 Sep; 212(5):459-69. PubMed ID: 19181573
[TBL] [Abstract][Full Text] [Related]
12. Organochlorine compounds and thyroid dysfunction in children: is there a link with neurotoxicity?
Chatzi L
Occup Environ Med; 2008 Jul; 65(7):437. PubMed ID: 18562682
[No Abstract] [Full Text] [Related]
13. Anesthetic-related neurotoxicity in the developing infant: of mice, rats, monkeys and, possibly, humans.
McGowan FX; Davis PJ
Anesth Analg; 2008 Jun; 106(6):1599-602. PubMed ID: 18499584
[No Abstract] [Full Text] [Related]
14. [Amalgam: a risk assessment using a review of the latest literature through 2005].
Halbach S
Gesundheitswesen; 2006 Apr; 68(4):e1-6; discussion e6-15. PubMed ID: 16705556
[No Abstract] [Full Text] [Related]
15. Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity.
Bal-Price A; Meek MEB
Pharmacol Ther; 2017 Nov; 179():84-95. PubMed ID: 28529068
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles, Neurotoxicity and Neurodegenerative Diseases.
Mushtaq G; Khan JA; Joseph E; Kamal MA
Curr Drug Metab; 2015; 16(8):676-84. PubMed ID: 26264205
[TBL] [Abstract][Full Text] [Related]
17. Severe encephalopathy caused by intraparenchymal methotrexate instillation due to the design of the catheter.
Gottschling S; Reinhard H; Meyer S; Krenn T; Graf N; Strowitzki M
Med Pediatr Oncol; 2003 Nov; 41(5):491-2. PubMed ID: 14515401
[No Abstract] [Full Text] [Related]
18. Movement disorders.
Minagar A; Kelley RE
Prim Care; 2004 Mar; 31(1):111-27. PubMed ID: 15110162
[No Abstract] [Full Text] [Related]
19. Nerve agents: a comprehensive review.
Wiener SW; Hoffman RS
J Intensive Care Med; 2004; 19(1):22-37. PubMed ID: 15035752
[TBL] [Abstract][Full Text] [Related]
20. Cefepime: serious neurological adverse effects.
Prescrire Int; 2015 Jan; 24(156):20. PubMed ID: 25729829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
